Nathan Treybeck
Stock Analyst at Wells Fargo
(1.42)
# 3,525
Out of 5,173 analysts
27
Total ratings
29.41%
Success rate
-1.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $51 → $34 | $25.79 | +31.83% | 10 | Feb 26, 2026 | |
| LMAT LeMaitre Vascular | Maintains: Equal-Weight | $87 → $94 | $106.31 | -11.58% | 3 | Feb 26, 2026 | |
| IRTC iRhythm Holdings | Maintains: Overweight | $225 → $200 | $116.28 | +72.00% | 7 | Feb 20, 2026 | |
| ITGR Integer Holdings | Maintains: Equal-Weight | $72 → $84 | $84.10 | -0.12% | 5 | Feb 20, 2026 | |
| RMD ResMed | Maintains: Equal-Weight | $265 → $270 | $225.99 | +19.47% | 2 | Jan 30, 2026 |
PROCEPT BioRobotics
Feb 26, 2026
Maintains: Overweight
Price Target: $51 → $34
Current: $25.79
Upside: +31.83%
LeMaitre Vascular
Feb 26, 2026
Maintains: Equal-Weight
Price Target: $87 → $94
Current: $106.31
Upside: -11.58%
iRhythm Holdings
Feb 20, 2026
Maintains: Overweight
Price Target: $225 → $200
Current: $116.28
Upside: +72.00%
Integer Holdings
Feb 20, 2026
Maintains: Equal-Weight
Price Target: $72 → $84
Current: $84.10
Upside: -0.12%
ResMed
Jan 30, 2026
Maintains: Equal-Weight
Price Target: $265 → $270
Current: $225.99
Upside: +19.47%